non-small cell lung cancerNSCLCBrMimmune checkpoint inhibitorsICI therapyICIs
…Background Brain metastases (BrM) in non-small cell lung cancer (NSCLC) present a significant challenge due to poor prognosis. …
126articles mentioning diseases
162disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: non-small cell lung cancer ×
non-small cell lung cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning non-small cell lung cancer
126 articles · page 6 of 11NSCLCNon-small cell lung cancersolid malignanciesAnti-PD-(L)1santi-PD-(L)1anti-PD-(L)1-basedAmerican Society of Clinical Oncology
…DFS/PFS presented R² 0.39 across all RCTs (51 ICs), and 0.65 in NSCLC (21 ICs; p<0.01).Conclusions Early use of anti-PD-(L)1 therapy …
non-small cell lung cancerrenal cell carcinomaurothelial carcinoma (n=4); gastric/gastro-oesophageal cancerhepatocellular carcinomacervical cancertriple-negative breast cancersmall cell lung cancermelanomahead and neck squamous cell carcinomaovarian/fallopian/peritoneal cancer+3 more
…herapy.These studies included the following solid cancer types: non-small cell lung cancer (n=9); small cell lung cancer (n=2); melanoma (cutaneous and ad…
NSCLCnon-small cell lung cancerimmunotherapyWCG IRBMETamp
…d with METex14 subtypes was used to impute subtypes in a second NSCLC cohort with immunotherapy outcomes (N=205).Results METex14 tumo…
renal cell carcinomamelanomanon-small cell lung cancerNSIGCcancerUniversity of Oklahoma
…ma (51.8%; n=73), non-small cell lung cancer (16.3%; n=23), and renal cell carcinoma (6.4%; n=9). Our result showed a significant difference between…
melanomaHodgkin lymphomanon-small cell lung cancerhepatocellular carcinomahead and neck squamous cell carcinomarenal cell carcinomaRCCimmune checkpoint inhibitors
…ed patients. Grade ≥3 irAEs are projected at 12,289 cases, with melanoma and RCC showing highest per-patient risks (30% and 25%, respect…
non-small cell lung cancerNSCLCdurvalumabdurvalumab-relatedchemoradiationcarboplatin
…Background One-third of patients with non-small cell lung cancer (NSCLC) are diagnosed with stage III, locally advanced disease.…
NSCLCnon-small cell lung cancerSLERApsoriasisIBDpembrolizumabnivolumabCohort 1Cohort 2+1 more
… development of early toxicity mitigation strategies in routine NSCLC practice.Acknowledgements This study was conducted using de-ide…
non-small cell lung cancerNSCLCneoadjuvant chemotherapyTianjin Medical University Cancer Institute and Hospitalimmune checkpoint inhibitorsICIs
… complete response (pCR) and major pathologic response (MPR) in non-small cell lung cancer (NSCLC) patients receiving neoadjuvant chemotherapy combined wi…
non-small cell lung cancerMelanomaButyrateICB
…as revolutionised the treatment of cancers such as Melanoma and non-small cell lung cancer. However, many patients do not respond to ICB whilst some cance…
endometrial carcinomanon-small cell lung cancercervical canceradvanced renal cell carcinomahepatocellular carcinomaCTX-10726Compass Therapeutics
…r, advanced renal cell carcinoma, hepatocellular carcinoma, and endometrial carcinoma. The simultaneous targeting of VEGF-A and PD-1 in a single mole…
NSCLCnon-small cell lung cancerpembrolizumabnivolumabKEYNOTE-189KEYNOTE-407ipilimumabCM9LA
… demonstrated a stronger long-term survival signal. In squamous NSCLC, both regimens had comparable early outcomes, with CM9LA again …